BioVie (BIVI)
(Delayed Data from NSDQ)
$2.76 USD
-0.07 (-2.47%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $2.75 -0.01 (-0.36%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for BioVie Inc falls in the month of June .
All items in Millions except EPS data.
6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | |
---|---|---|---|---|---|
Sales | NA | 0 | 0 | 0 | 0 |
Cost Of Goods | NA | 0 | 0 | 0 | 0 |
Gross Profit | NA | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 45 | 27 | 138 | 3 |
Income After Depreciation & Amortization | 0 | -45 | -27 | -138 | -3 |
Non-Operating Income | NA | -1 | 3 | 8 | -9 |
Interest Expense | NA | 4 | 2 | 1 | 5 |
Pretax Income | NA | -50 | -26 | -130 | -17 |
Income Taxes | NA | 0 | 0 | 0 | 0 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | -50 | -26 | -130 | -17 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
Net Income (GAAP) | NA | -50 | -26 | -130 | -17 |
Depreciation Footnote | 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | -45 | -27 | -138 | -2 |
Depreciation & Amortization (Cash Flow) | NA | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | 0 | -45 | -27 | -138 | -3 |
Earnings Per Share Data | 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 |
---|---|---|---|---|---|
Average Shares | NA | 3.25 | 2.47 | 1.24 | 0.49 |
Diluted EPS Before Non-Recurring Items | NA | -15.50 | -10.60 | -148.20 | -68.50 |
Diluted Net EPS (GAAP) | NA | -15.50 | -10.60 | -148.20 | -68.50 |
Fiscal Year end for BioVie Inc falls in the month of June .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 7.73 | 8.78 | 10.88 | 10.98 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -7.73 | -8.78 | -10.88 | -10.98 |
Non-Operating Income | NA | 0.29 | 1.20 | 1.17 | 2.97 |
Interest Expense | NA | 0.63 | 0.82 | 1.00 | 1.11 |
Pretax Income | NA | -8.07 | -8.40 | -10.71 | -9.11 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -8.07 | -8.40 | -10.71 | -9.11 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -8.07 | -8.40 | -10.71 | -9.11 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 4.48 | 3.82 | 3.67 | 3.25 |
Diluted EPS Before Non-Recurring Items | NA | -2.00 | -2.20 | -2.90 | -2.30 |
Diluted Net EPS (GAAP) | NA | -2.00 | -2.20 | -2.90 | -2.40 |